Dose-dependent effect of atorvastatin on long-term kidney function and associated cardiovascular outcomes von Vogt, L, Bangalore, S, Fayyad, R, Laskey, R, Hovingh, G.K, DeMicco, D.A, Waters, D

Volltext

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial von Soedamah-Muthu, Sabita S., Livingstone, Shona J., Charlton-Menys, Valentine, Betteridge, D. John, Hitman, Graham A., Neil, H. Andrew W., Bao, Weihang, DeMicco, David A., Preston, Gregory M., Fuller, John H., Stehouwer, Coen D. A., Schalkwijk, Casper G., Durrington, Paul N., Colhoun, Helen M.

Volltext

482 C-REACTIVE PROTEIN (CRP) AND LIPID LEVELS TO PREDICT THE RISK OF CORONARY HEART DISEASE IN STATIN-TREATED STABLE CORONARY PATIENTS von Arsenault, B.J., Boekholdt, S.M., Deedwania, P., DeMicco, D.A., Bao, W.H., Preston, G.M., Waters, D.D., LaRosa, J.C., Barter, P., Kastelein, J.J.P.

Volltext

624 THE TRP719ARG VARIANT OF KIF6 AND CARDIOVASCULAR OUTCOMES IN STATIN-TREATED CORONARY STABLE PATIENTS OF THE TNT AND IDEAL PROSPECTIVE STUDIES von Arsenault, B.J., Boekholdt, S.M., Hovingh, G.K., Hyde, C.L., DeMicco, D.A., Chatterjee, A., Barter, P., Deedwania, P., Waters, D.D., LaRosa, J.C., Pedersen, T.R., Kastelein, J.J.R

Volltext

The effect of Atorvastatin therapy tumour necrosis factor- and vascular adhesion molecules in patients with type 2 diabetes mellitus with no prior history of coronary heart disease von Soedamah-Muthu, S.S, Charlton-Menys, V, Bao, W, Schalkwijk, C.G, Stehouwer, C.D.A, Colhoun, H.M, Betteridge, D.J, Durrington, P, Hitman, G, Neil, H.A.W, Livingstone, S.J, Fuller, J.H, DeMicco, D.A, Preston, G.M

Volltext

PO23-737 A COMPARISON OF THE ASSOCIATION OF ON-TREATMENT LIPID AND APOLIPOPROTEIN PARAMETERS TO CARDIOVASCULAR EVENTS IN IDEAL AND TNT von Kastelein, J.J., Holme, I., van der Steeg, W.A., Barter, P., Olsson, A.G., Cater, N.B., DeMicco, D.A., Gaffney, M., Szarek, M., LaRosa, J.C., Pedersen, T.R.

Volltext